An interventional study of Hight-intensity magnetic therapy and Closed Kinetic Chain Exercises in Femoropatellar Pain Syndrome, sponsored by University Rovira i Virgili. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by University Rovira i Virgili · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 597 studies in Motor Activity with a site in Spain — 148 open to participants now, 184 under way, 1 of them phase 3. Motor Activity · Spain.
Among the 597 studies in Motor Activity with a site in Spain, this one is the 433rd largest by planned enrollment of the 539 interventional ones that give a count, is one of 45 that started in 2021, is one of 515 with no phase, reaches primary completion later than 95 of the 183 other live ones, and was the 597th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →148 of the 597 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:
Universidad Pública de Navarra · Sites in Spain
Ages 65+
University of Valencia · Sites in Spain
Ages 60–99
Universidad San Jorge · Sites in Spain
Ages 18–65 · Healthy volunteers
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 18+ · Women only
Alberto Bermejo Franco · Sites in Spain
Ages 70+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
597 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 9 · Phase 4 4
First in 2004; this study’s year is marked. 45 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 36 is below the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 80 across the 539 interventional studies, 145 across the 58 observational. Of the 335 that completed or were terminated, 5 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 597 have an industry lead sponsor. The 10 most frequent:
University Rovira i Virgili is the lead sponsor of 53 studies on the registry; 10 are open to participants now.
University Rovira i Virgili has 4 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
47 of the studies in Motor Activity with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07183241Universidad Pública de NavarraHospital-to-Home Rehabilitation Through Exercise and Cognitive Training | 2026-12 |
| NCT07489391University of DeustoConcomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer | 2026-12 |
| NCT07232511University of ValenciaExercise-induced Hypoalgesia Effects of Blood Flow Restriction in People With Rotator Cuff-related Shoulder Pain | 2026-12 |
| NCT06446596University of ValenciaTelerehabilitation-based Exercises vs Standard Home-based Exercise in Low Back Pain | 2026-12 |
| NCT06948500Cardenal Herrera UniversityEffectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients | 2026-12-01 |
Add all 47 to your calendar (.ics) → With an account.
Among the 597 studies in Motor Activity with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Detailed Description:
Patellofemoral Pain Syndrome (PFPS) is one of the most frequent causes of anterior knee pain in clinical practice. It is primarily caused by mechanical dysfunctions and muscular imbalances between the patella and the femur, particularly involving weak quadriceps and hip stabilizing muscles.
Currently, supervised closed kinetic chain exercises targeting the knee and hip are considered standard conservative therapy due to their long-term effectiveness in stabilizing joint mechanics. High-intensity magnetic therapy is an innovative, non-invasive physical therapy modality that applies pulsed magnetic fields at a short distance (approximately 1 cm from the knee) to manage acute and chronic musculoskeletal pain. However, scientific evidence regarding the added clinical benefits of high-intensity magnetic therapy when combined with exercise for patellofemoral pain remains limited.
Study Hypothesis:
Combining high-intensity magnetic therapy with closed kinetic chain exercises for the knee and hip will produce greater improvements in knee pain reduction and functional recovery than closed kinetic chain exercises alone in patients with patellofemoral chondropathy.
Study Design and Interventions:
This randomized intervention study includes adult male and female participants with a clinical and radiological diagnosis of patellofemoral chondropathy.
To participate in the study, all candidate participants must fulfill all specified eligibility and inclusion criteria and provide signed written informed consent prior to enrollment.
Participants are randomly assigned in a treatment groups:
Group 1 (Exercise Alone): Participants complete 20 daily treatment sessions (Monday through Friday) consisting of supervised closed kinetic chain exercises designed to strengthen the stabilizing muscles of the knee and hip joint. Exercises consist of 10 repetitions per exercise during the first 10 sessions, increasing to 2 sets of 10 repetitions for the remaining 10 sessions.
Group 2 (High-Intensity Magnetic Therapy + Exercise): Participants receive 15 minutes of non-invasive high-intensity magnetic therapy applied to the knee (frequency: 3-15 Hz; intensity: 75-100% adapted to individual pain threshold) immediately followed by the exact same exercise protocol as Group 1.
Evaluations and Outcomes:
Participant assessments take place at three time points: baseline (prior to intervention), post-treatment (immediately following session 20), and at 1-month follow-up. The primary outcome is pain. Secondary outcomes include physical activity levels, sleep quality, knee joint range of motion, thigh muscle circumference, Body Mass Index (BMI), and anatomical patellofemoral measurements.
Inclusion Criteria:
Exclusion Criteria:
Study Scales, Questionnaires, and Assessment Tools:
To collect data and evaluate participants across the three assessment visits of the study, the following scales, questionnaires, and clinical evaluation tools were used:
Initial Anamnesis: In addition to the clinical scales, during the first visit, a comprehensive anamnesis was conducted to collect the following participant data: age, sex, height, weight and profession.
List of Scales and Assessment Tools:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants complete 20 daily treatment sessions (Monday through Friday) consisting of supervised closed kinetic chain exercises designed to strengthen the stabilizing muscles of the knee and hip joint. Exercises consist of 10 repetitions per exercise during the first 10 sessions, increasing to 2 sets of 10 repetitions for the remaining 10 sessions.
Other: Closed Kinetic Chain Exercises
Participants receive 15 minutes of non-invasive high-intensity magnetic therapy applied to the knee (frequency: 3-15 Hz; intensity: 75-100% adapted to individual pain threshold) immediately followed by the exact same exercise protocol as Group 1.
Device: Hight-intensity magnetic therapy · Other: Closed Kinetic Chain Exercises
Application of pulsed high-intensity magnetic therapy to the knee for 15 minutes per session (frequency: 3-15 Hz; intensity: 75-100% according to pain threshold).
Also known as: Repetitive peripheral magnetic stimulation
Supervised closed kinetic chain exercises targeting the stabilizing muscles of the knee and hip joints (10 repetitions per exercise for sessions 1-10, increased to 2 sets of 10 repetitions for sessions 11-20).
Change in knee pain intensity.
Assessed using the Visual Analog Scale (VAS), where participants rate their knee pain on a 10 continuous scale ranging from 0 (no pain) to 10 (worst imaginable pain). The primary objective is to detect a clinically meaningful difference between intervention groups.
Time frame: Baseline (prior to session 1), Post-intervention (immediately after 20 treatment sessions), and 1-month follow-up.
Change in knee joint range of motion (ROM).
Measured in degrees of knee flexion and extension using a standard clinical goniometer.
Time frame: Baseline, post-intervention (after 20 sessions), and 1-month follow-up.
Change in thigh muscle circumference.
Measured in centimeters (cm) using a measuring tape placed 5 cm above the upper border of the patella in standing position, with knee extension and under active quadriceps muscle contraction, to assess muscle volume compared to the healthy limb.
Time frame: Baseline, post-intervention (after 20 sessions), and 1-month follow-up.
Change in sleep quality.
Evaluated using the Pittsburgh Sleep Quality Index (PSQI) questionnaire to assess overall sleep quality and disturbances.
Time frame: Baseline, post-intervention (after 20 sessions), and 1-month follow-up.
Change in patellofemoral anatomical angles.
Measuring the Q-angle with a goniometer in degrees.
Time frame: Baseline, oost-intervention (after 20 sessions) and 1-month follow-up.
Physical activity level.
Evaluated using the International Physical Activity Questionnaire (IPAQ) to categorize participants' physical activity levels.
Time frame: Baseline only.
Baseline Body Mass Index (BMI).
Calculated as weight in kilograms divided by height in meters squared (kg/m²).
Time frame: Baseline only.
Baseline patellar shape classification.
Morphological classification of the patella evaluated on radiographic images according to Wiberg's criteria.
Time frame: Baseline only.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2021 to primary completion in Aug 2026, 56 months.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 56 months is above that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Rovira i Virgili